Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study.
Mohammad Daud AliLeena Zakariya AlmadanRuba Ahmed AlghamdiAlanood Saleh AlghamdiSarah Ali AlmarhoonYousif Amin HassanAyaz AhmadSherihan Ahmad GhosnNuzhat BanuZainab EltrafiPublished in: Infection and drug resistance (2022)
According to this study, the Pfizer-BioNTech/BNT162b2 COVID-19 vaccine was safe when given to Saudi Arabian HCWs. All reported side-effects were mild to moderate. The outcomes indicated that most participants had body pain and pain at the site of injection and fatigue is among the least reported side-effect post-booster dose. Healthcare was highly connected with more reporting of side-effects.
Keyphrases
- saudi arabia
- coronavirus disease
- sars cov
- chronic pain
- healthcare
- south africa
- pain management
- neuropathic pain
- respiratory syndrome coronavirus
- spinal cord injury
- adverse drug
- emergency department
- physical activity
- insulin resistance
- postoperative pain
- sleep quality
- binding protein
- health information
- glycemic control
- electronic health record
- drug induced